Gefitinib Pharmaceutical Reference Standards

Aligns Pharma science supply high-quality impurities reference standards of Gefitinib, pharmacopeial and non-pharmacopeial Gefitinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Gefitinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Gefitinib is used to treat lung cancer. Acting in a similar manner to erlotinib gefitinib selectively targets the mutant proteins in malignant cells. It is marketed by AstraZeneca under the trade name Iresa.

Our Gefitinib impurities reference standard offering includes

• Gefitinib related products are thoroughly characterized with NMR, MASS, IR and HPLC/ GC purity.
• Gefitinib products are supplied with detailed COA & analytical data meeting regulatory compliance.
• We can also provide Gefitinib EP/USP traceable standards based on your requirements.
• The supplied Gefitinib related products are re-tested at regular intervals.